6.40Open6.40Pre Close0 Volume2 Open Interest22.50Strike Price0.00Turnover107.66%IV11.03%PremiumDec 20, 2024Expiry Date4.41Intrinsic Value100Multiplier17DDays to Expiry2.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7891Delta0.0686Gamma3.75Leverage Ratio-0.0334Theta-0.0075Rho-2.96Eff Leverage0.0114Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet